127 related articles for article (PubMed ID: 20667008)
1. Clinico-pathological feature of pilomyxoid astrocytomas: three case reports.
Nagaishi M; Yokoo H; Hirato J; Yoshimoto Y; Nakazato Y
Neuropathology; 2011 Apr; 31(2):152-7. PubMed ID: 20667008
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.
Johnson MW; Eberhart CG; Perry A; Tihan T; Cohen KJ; Rosenblum MK; Rais-Bahrami S; Goldthwaite P; Burger PC
Am J Surg Pathol; 2010 Dec; 34(12):1783-91. PubMed ID: 21107083
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas.
Amatya VJ; Akazawa R; Sumimoto Y; Takeshima Y; Inai K
Pathol Int; 2009 Feb; 59(2):80-5. PubMed ID: 19154260
[TBL] [Abstract][Full Text] [Related]
4. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
6. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological features of pilomyxoid astrocytoma of the optic pathway.
Chikai K; Ohnishi A; Kato T; Ikeda J; Sawamura Y; Iwasaki Y; Itoh T; Sawa H; Nagashima K
Acta Neuropathol; 2004 Aug; 108(2):109-14. PubMed ID: 15168135
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological Study of Pilomyxoid-Spectrum Astrocytomas:An Analysis of the BRAF Gene. Report of Two Cases].
Ito T; Sato K; Oikawa M; Sugio H; Asanome T; Ozaki Y; Nakamura H; Tanaka S; Tsuda M; Nagashima K
No Shinkei Geka; 2015 Sep; 43(9):825-33. PubMed ID: 26321697
[TBL] [Abstract][Full Text] [Related]
9. Management of pilomyxoid astrocytomas: our experience.
Tsugu H; Oshiro S; Yanai F; Komatsu F; Abe H; Fukushima T; Nomura Y; Matsumoto S; Nabeshima K; Takano K; Utsunomiya H
Anticancer Res; 2009 Mar; 29(3):919-26. PubMed ID: 19414328
[TBL] [Abstract][Full Text] [Related]
10. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
11. Pilomyxoid astrocytoma of the pineal region: cytopathological features and differential diagnostic considerations by intraoperative smear preparation.
Hayashi T; Haba R; Kushida Y; Katsuki N; Shibuya S; Kadota K; Matsunaga T; Miyake K; Tamiya T
Diagn Cytopathol; 2015 Feb; 43(2):121-4. PubMed ID: 24578310
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for early symptomatic recurrence in pilocytic astrocytoma: does angiogenesis have a role to play?
Kurwale NS; Suri V; Suri A; Sarkar C; Gupta DK; Sharma BS; Mahapatra AK
J Clin Neurosci; 2011 Apr; 18(4):472-7. PubMed ID: 21292490
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
14. Pilomyxoid astrocytoma: neuroimaging with clinicopathologic correlates in 4 cases followed over time.
Komakula ST; Fenton LZ; Kleinschmidt-DeMasters BK; Foreman NK
J Pediatr Hematol Oncol; 2007 Jul; 29(7):465-70. PubMed ID: 17609624
[TBL] [Abstract][Full Text] [Related]
15. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
16. Pediatric cerebellar pilomyxoid-spectrum astrocytomas.
Forbes JA; Mobley BC; O'Lynnger TM; Cooper CM; Ghiassi M; Hanif R; Pearson MM
J Neurosurg Pediatr; 2011 Jul; 8(1):90-6. PubMed ID: 21721894
[TBL] [Abstract][Full Text] [Related]
17. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
Kamiya M; Nakazato Y
Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of urokinase-type plasminogen activator in human gliomas.
Hsu DW; Efird JT; Hedley-Whyte ET
Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
[TBL] [Abstract][Full Text] [Related]
19. Late malignant recurrence of childhood cerebellar astrocytoma.
Casadei GP; Arrigoni GL; D'Angelo V; Bizzozero L
Clin Neuropathol; 1990; 9(6):295-8. PubMed ID: 2286021
[TBL] [Abstract][Full Text] [Related]
20. Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas.
Komotar RJ; Burger PC; Carson BS; Brem H; Olivi A; Goldthwaite PT; Tihan T
Neurosurgery; 2004 Jan; 54(1):72-9; discussion 79-80. PubMed ID: 14683543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
